Martin Quibell

No más puestos en curso

Health Technology

Consumer Services

Perfil

Martin Quibell is the founder and Chief Scientific Officer at Pedanius Therapeutics Ltd. which is founded in 2018.
He previously held positions as Director-Medicinal Chemistry at Acambis Plc, Vice President-Medicinal Chemistry at Amura Holdings Ltd. and Amura Therapeutics Ltd., and Principal at Incenta Ltd. Dr. Quibell earned a doctorate degree from the University of Birmingham in 1991 and an undergraduate degree from the University of Portsmouth.

Antiguos cargos conocidos de Martin Quibell.

Empresas	Cargo	Fin
Incenta Ltd.	Corporate Officer/Principal	-
Amura Therapeutics Ltd.	Corporate Officer/Principal	-
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Corporate Officer/Principal	-
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Martin Quibell.

Formación de Martin Quibell.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Martin Quibell.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Health Technology
University of Birmingham University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Portsmouth University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Health Technology
Amura Therapeutics Ltd.
Incenta Ltd.